ISB Q&A Archives

A New Approach to Alzheimer’s Disease

Posted on April 21, 2021

The impact of Alzheimer’s Disease is staggering – 6 million Americans diagnosed, a financial toll of $600 billion annually, and no effective drug treatments. ISB Co-founder Dr. Lee Hood said the traditional approach isn’t working, and we need to think about it in brand new ways.

ISB’s Dr. Qiang Tian Joins Shanghai’s National Research Center for Translational Medicine

Posted on March 26, 2019

In the two decades since joining Dr. Lee Hood as a postdoc, Dr. Qiang Tian has made a tremendous impact on ISB’s science and culture. March 31 is his final day at ISB, as he is returning to China and joining Shanghai’s National Research Center for Translational Medicine.

A New Approach to Alzheimer’s Disease

at the Institute for Systems Biology

News

A New Approach to Alzheimer’s Disease

ISB’s Dr. Qiang Tian Joins Shanghai’s National Research Center for Translational Medicine

Sitemap